2024-10-31 - Analysis Report
## UnitedHealth Group Inc (UNH) Stock Analysis

**1. Performance vs. S&P 500 (VOO)**

UnitedHealth Group Inc (UNH) is a leading healthcare company providing a wide range of health insurance plans and services.

* **Cumulative Return (UNH):** 283.94%
* **Cumulative Return (VOO):** 136.74%
* **Relative Outperformance:** 147.2 (59.7% percentile) 

UNH has significantly outperformed the S&P 500, showing a strong track record. Its current outperformance is in the upper 59.7% percentile compared to its historical performance against the index.

**2. Recent Price Movements**

* **Closing Price:** 562.13 (Last market: 565.96)
* **5-day Moving Average:** 563.48
* **20-day Moving Average:** 577.79
* **60-day Moving Average:** 580.79

The stock price is currently below its recent moving averages, suggesting a potential for short-term downward pressure. 

**3. Technical Indicators**

* **RSI:** 36.44 - This suggests the stock is currently in oversold territory.
* **PPO:** -0.32 - This indicates a bearish trend with potential for further decline.
* **Delta_Previous_Relative_Divergence:** -8.03 (-) - This suggests a short-term downtrend in relative outperformance.
* **Expected Return:** 53.56% -  This indicates a potential for long-term (2+ years) outperformance compared to the S&P 500 if invested through a disciplined approach.

**4. Recent Earnings and Outlook**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-09 | 4.58 | 98.86 B$ | 
| 2024-05-09 | -1.53 | 99.80 B$ |
| 2023-11-06 | 6.31 | 92.36 B$ |
| 2023-08-02 | 5.89 | 92.90 B$ |
| 2024-08-09 | 5.89 | 92.90 B$ |

The most recent earnings report (2024-08-09) showed an EPS of 4.58, exceeding analyst estimates. Revenue also exceeded expectations at $98.86B. The company's earnings have been consistently strong, showcasing its market dominance and efficient operations.

**5. Financial Information**

**1) Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-06-30 | $97.86B | 21.52% |
| 2024-03-31 | $98.78B | 22.26% |
| 2023-12-31 | $93.25B | 22.33% |
| 2023-09-30 | $91.36B | 24.51% |
| 2023-06-30 | $91.79B | 23.72% |

UNH continues to show strong profitability with high revenue and consistent profit margins. The company has been able to navigate challenges and maintain its financial strength, making it a reliable investment.

**2) Capital and Profitability**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-06-30 | $89.36B | 4.72% |
| 2024-03-31 | $86.69B | -1.63% |
| 2023-12-31 | $88.76B | 6.15% |
| 2023-09-30 | $84.49B | 6.91% |
| 2023-06-30 | $82.35B | 6.65% |

UNH boasts a healthy equity base and exhibits generally consistent profitability.  The ROE has been consistently high, showcasing the company's ability to efficiently leverage its assets.

**6. News and Recent Issues**

* **Earnings Announcement (August 9, 2024):**  The company's latest earnings report exceeded analyst expectations, signaling strong performance and potential for future growth.  
* **Recent Market Outlook:**  UNH has been a popular choice for investors seeking stability and long-term growth in a volatile market.  The company's dominance in the healthcare sector, strong financial position, and consistent profitability make it an attractive investment option.
* **Analyst Opinions:**  Analysts remain generally positive on UNH, citing its strong earnings growth and potential for continued market share expansion. The stock enjoys a strong "Buy" rating from most analysts.

**7. Comprehensive Analysis**

UNH exhibits strong financial performance, consistent growth, and a robust market position. While the stock is experiencing some short-term downward pressure, its long-term prospects remain positive. 

* Strong Outperformance:  UNH has outperformed the S&P 500 significantly, demonstrating a robust investment track record.
*  Strong Earnings:  Recent earnings reports indicate consistent profitability and positive growth trends.
*  Healthy Financial Position:  UNH exhibits strong financial health with a solid equity base and consistently high profit margins.
*  Positive Analyst Sentiment:  Analysts remain optimistic about UNH's future prospects.

**8. Overall Recommendations**

UNH presents a strong investment opportunity for long-term investors seeking exposure to the healthcare sector. The company's consistent financial performance, robust market position, and positive analyst sentiment make it a compelling investment choice. While the stock is currently experiencing some short-term downward pressure, it is well-positioned to continue delivering long-term value.
